Journal articles on the topic 'Melanoma Screening Trial (MST)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Melanoma Screening Trial (MST).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Elwood, J. M. "Screening for Melanoma and Options For-Its Evaluation." Journal of Medical Screening 1, no. 1 (January 1994): 22–38. http://dx.doi.org/10.1177/096914139400100107.
Full textDjavid, Amir Reza, Connor Stonesifer, Benjamin T. Fullerton, Samuel W. Wang, Marlene A. Tartaro, Bradley D. Kwinta, Joseph M. Grimes, Larisa J. Geskin, and Yvonne M. Saenger. "Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence." Cancers 13, no. 19 (September 30, 2021): 4914. http://dx.doi.org/10.3390/cancers13194914.
Full textPrimiero, Clare Amy, Aideen M. McInerney-Leo, Brigid Betz-Stablein, David C. Whiteman, Louisa Gordon, Liam Caffery, Joanne F. Aitken, et al. "Evaluation of the efficacy of 3D total-body photography with sequential digital dermoscopy in a high-risk melanoma cohort: protocol for a randomised controlled trial." BMJ Open 9, no. 11 (November 2019): e032969. http://dx.doi.org/10.1136/bmjopen-2019-032969.
Full textMatias, Mariana, Jacinta O. Pinho, Maria João Penetra, Gonçalo Campos, Catarina Pinto Reis, and Maria Manuela Gaspar. "The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval." Cells 10, no. 11 (November 9, 2021): 3088. http://dx.doi.org/10.3390/cells10113088.
Full textColman, Howard, Ken Boucher, Chris Stehn, David Kircher, and Sheri Holmen. "THER-07. DEVELOPMENT OF A NEW MOLECULAR PREDICTOR FOR RISK OF BRAIN METASTASES AND EFFICACY OF TARGETED THERAPY IN MELANOMA." Neuro-Oncology Advances 1, Supplement_1 (August 2019): i12. http://dx.doi.org/10.1093/noajnl/vdz014.050.
Full textSarasamma, Sreeja, Yu-Heng Lai, Sung-Tzu Liang, Kechun Liu, and Chung-Der Hsiao. "The Power of Fish Models to Elucidate Skin Cancer Pathogenesis and Impact the Discovery of New Therapeutic Opportunities." International Journal of Molecular Sciences 19, no. 12 (December 7, 2018): 3929. http://dx.doi.org/10.3390/ijms19123929.
Full textKok, Peey-Sei, Won-Hee Yoon, Sally Lord, Ian Marschner, Michael Friedlander, and Chee Khoon Lee. "Tumor Response End Points as Surrogates for Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-Analysis." JCO Precision Oncology, no. 5 (July 2021): 1151–59. http://dx.doi.org/10.1200/po.21.00108.
Full textBrastianos, Priscilla Kaliopi, Erin Twohy, Carey K. Anders, A. John Iafrate, Peter A. Kaufman, Justine Vanessa Cohen, Rebecca Suk Heist, et al. "Alliance A071701: Genomically guided treatment trial in brain metastases." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): TPS2573. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.tps2573.
Full textShah, Payal D., Alexander Chan Chi Huang, Xiaowei Xu, Paul J. Zhang, Robert Orlowski, Tina Matlawski, Joanne Shea, et al. "Phase I trial of autologous cMET-directed CAR-t cells administered intravenously in patients with melanoma & breast carcinoma." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 10035. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.10035.
Full textSimonelli, Matteo, Emiliano Calvo, Diwakar Davar, Jason Melear, Donald Richards, Matthew Dallos, Martin Gutierrez, et al. "Abstract CT119: A randomized, double-blind phase 2 evaluation of the anti-IL-8 monoclonal antibody BMS-986253 + nivolumab + ipilimumab vs nivolumab + ipilimumab in patients with advanced melanoma that progressed on/after anti-PD-(L)1 therapy." Cancer Research 82, no. 12_Supplement (June 15, 2022): CT119. http://dx.doi.org/10.1158/1538-7445.am2022-ct119.
Full textSamlowski, Wolfram E., James Moon, Merle Witter, Michael B. Atkins, John M. Kirkwood, Megan Othus, Antoni Ribas, Vernon K. Sondak, and Lawrence E. Flaherty. "CNS metastases as a site of progression on SWOG intergroup study S0008: A phase III trial of high-dose interferon alpha-2b versus cisplatin, vinblastine, DTIC plus IL-2 (BCT) versus high-dose interferon (HDI) in patients with high-risk melanoma." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 8527. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.8527.
Full textIglesias, Jose Luis, Radha Prathikanti, Bo Ma, Paulette Mattson, Deb Kedrowski, Jamie Lowe, Nandita Bose, et al. "A multicenter, open-label, phase II study of PGG beta-glucan and pembrolizumab in patients (pts) with advanced melanoma (MEL) following progression on treatment with checkpoint inhibitors (CPI) or triple negative breast cancer (TNBC) failing front-line chemotherapy for metastatic disease." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): TPS3105. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.tps3105.
Full textLam, Megan, Justin Di Lu, Levi Elhadad, Cathryn Sibbald, and Raed Alhusayen. "Common Dermatologic Disorders in Down Syndrome: Systematic Review." JMIR Dermatology 5, no. 1 (February 8, 2022): e33391. http://dx.doi.org/10.2196/33391.
Full textHamid, Omid, Ding Wang, Tae Min Kim, Sang-We Kim, Nehal J. Lakhani, Melissa Lynne Johnson, Roman Groisberg, et al. "Clinical activity of fianlimab (REGN3767), a human anti-LAG-3 monoclonal antibody, combined with cemiplimab (anti-PD-1) in patients (pts) with advanced melanoma." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 9515. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.9515.
Full textShen, Yu, and Marvin Zelen. "Screening Sensitivity and Sojourn Time From Breast Cancer Early Detection Clinical Trials: Mammograms and Physical Examinations." Journal of Clinical Oncology 19, no. 15 (August 1, 2001): 3490–99. http://dx.doi.org/10.1200/jco.2001.19.15.3490.
Full textSharma, Sombeer, Aakash Deep, and Arun K. Sharma. "Current Treatment for Cervical Cancer: An Update." Anti-Cancer Agents in Medicinal Chemistry 20, no. 15 (October 27, 2020): 1768–79. http://dx.doi.org/10.2174/1871520620666200224093301.
Full textWang, Tianjiao, Jean-Marc Navenot, Stavros Rafail, Mark Carroll, Ruoxi Wang, Cheryl McAlpine, Swethajit Biswas, et al. "Abstract LB001: Identifying MAGE-A4-positive tumors for SPEAR T-cell therapies in HLA-A*02-eligible patients." Cancer Research 82, no. 12_Supplement (June 15, 2022): LB001. http://dx.doi.org/10.1158/1538-7445.am2022-lb001.
Full textDavar, Diwakar, Matteo Simonelli, Martin Gutierrez, Emiliano Calvo, Jason Melear, Sarina Piha-Paul, Donald Richards, et al. "394 Interleukin-8–neutralizing monoclonal antibody BMS-986253 plus nivolumab (NIVO) in biomarker-enriched, primarily anti–PD-(L)1–experienced patients with advanced cancer: initial phase 1 results." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A419. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0394.
Full textHellinen, Laura, Sina Bahrpeyma, Anna-Kaisa Rimpelä, Marja Hagström, Mika Reinisalo, and Arto Urtti. "Microscale Thermophoresis as a Screening Tool to Predict Melanin Binding of Drugs." Pharmaceutics 12, no. 6 (June 16, 2020): 554. http://dx.doi.org/10.3390/pharmaceutics12060554.
Full textAitken, J. F., J. M. Elwood, J. B. Lowe, D. W. Firman, K. P. Balanda, and I. T. Ring. "A randomised trial of population screening for melanoma." Journal of Medical Screening 9, no. 1 (March 2002): 33–37. http://dx.doi.org/10.1136/jms.9.1.33.
Full textTarhini, Ahmad A., Paul Lorigan, and Sancy Leachman. "Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy." American Society of Clinical Oncology Educational Book, no. 37 (May 2017): 651–60. http://dx.doi.org/10.1200/edbk_174930.
Full textMehta, M. P., A. Dagnault, P. Chabot, J. Suh, E. Chang, M. Fortin, R. Timmerman, J. Grecula, L. Eubank, and M. F. Renschler. "Identification of occult brain metastases amenable to stereotactic radiosurgery by motexafin gadolinium (MGd) based treatment planning MRI: Results of a phase II trial of MGd and whole brain radiotherapy (WBRT) with stereotactic radiosurgery (SRS)." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 2037. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.2037.
Full textShi, Yuankai, Suxia Luo, Huan Zhou, Shengyu Zhou, Shan An, Zishu Wang, Sheng Yang, Ning Li, Xiaoli Li, and Xinyi Yang. "Phase I study of LBL-007, a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody in patients with advanced solid tumors." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 2523. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.2523.
Full textSharman, Jeff Porter, Jerome H. Goldschmidt, John M. Burke, Beth A. Hellerstedt, Kristi McIntyre, Christopher A. Yasenchak, Thomas E. Boyd, et al. "CD30 expression in nonlymphomatous malignancies." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 3069. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.3069.
Full textCorcoran, Ryan Bruce, Gerald Steven Falchook, Jeffrey R. Infante, Omid Hamid, Wells A. Messersmith, Adil Daud, Eunice Lee Kwak, et al. "Pharmacodynamic and efficacy analysis of the BRAF inhibitor dabrafenib (GSK436) in combination with the MEK inhibitor trametinib (GSK212) in patients with BRAFV600 mutant colorectal cancer (CRC)." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 3507. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.3507.
Full textCust, A. E., J. F. Aitken, P. D. Baade, D. C. Whiteman, H. P. Soyer, and M. Janda. "Why a randomized melanoma screening trial may be a good idea." British Journal of Dermatology 179, no. 5 (September 20, 2018): 1227–28. http://dx.doi.org/10.1111/bjd.17089.
Full textHyde, Mark A., Douglas Grossman, Yelena P. Wu, Saundra Buys, Lisa H. Gren, and Mia Hashibe. "Vitamin D, melanoma risk, and tumor thickness in PLCO cancer screening trial patients." Journal of the American Academy of Physician Assistants 33, no. 6 (June 2020): 35–41. http://dx.doi.org/10.1097/01.jaa.0000662388.18867.42.
Full textMaeda, Tetsuo, Ukihide Tateishi, Shigenobu Suzuki, Yasuaki Arai, E. Edmund Kim, and Kazuro Sugimura. "Magnetic Resonance Screening Trial for Hepatic Metastasis in Patients with Locally Controlled Choroidal Melanoma." Japanese Journal of Clinical Oncology 37, no. 4 (April 1, 2007): 282–86. http://dx.doi.org/10.1093/jjco/hym018.
Full textClouthier, Derek L., Cindy Yang, Scott Lien, Diana Gray, Ilaria Colombo, Stephanie Lheureux, Jeremy Howard Lewin, et al. "A technical feasibility report on correlative studies from the investigator-initiated phase II study of pembrolizumab (Pembro) immunological response evaluation (INSPIRE)." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 11607. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.11607.
Full textZhang, Hongjun, Xiangnan Liu, Yong’an Chen, Rui Xu, and Shengli He. "KDOAM-25 Overcomes Resistance to MEK Inhibitors by Targeting KDM5B in Uveal Melanoma." BioMed Research International 2022 (September 28, 2022): 1–9. http://dx.doi.org/10.1155/2022/1556485.
Full textUrosevic, V., Ph Chollet, A. Adenis, J. Chauvergne, P. Fargeot, H. Roche, P. Kerbrat, M. A. Lentz, P. Fumoleau, and B. Chevallier. "Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC Clinical Screening Group." European Journal of Cancer 32, no. 1 (January 1996): 181–82. http://dx.doi.org/10.1016/0959-8049(95)00473-4.
Full textMarkham, Merry Jennifer, Kerri Wachter, Neeraj Agarwal, Monica M. Bertagnolli, Susan Marina Chang, William Dale, Catherine S. M. Diefenbach, et al. "Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology." Journal of Clinical Oncology 38, no. 10 (April 1, 2020): 1081. http://dx.doi.org/10.1200/jco.19.03141.
Full textHanrahan, P. F., C. A. D’Este, S. W. Menzies, T. Plummer, and P. Hersey. "A randomised trial of skin photography as an aid to screening skin lesions in older males." Journal of Medical Screening 9, no. 3 (September 1, 2002): 128–32. http://dx.doi.org/10.1136/jms.9.3.128.
Full textThompson, John F., Mario Santinami, Thomas Jouary, Eugeny Levchenko, Bernard Mark Smithers, Laurent Mortier, Jean Jacques Grob, et al. "MAGE-A3 expression in patients screened for the DERMA trial: A phase III trial testing MAGE-A3 immunotherapeutic in the adjuvant setting for stage IIIB-C-Tx melanoma." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 8559. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.8559.
Full textLyle, Megan, and Georgina V. Long. "Diagnosis and Treatment ofKIT-Mutant Metastatic Melanoma." Journal of Clinical Oncology 31, no. 26 (September 10, 2013): 3176–81. http://dx.doi.org/10.1200/jco.2013.50.4662.
Full textMarshall, Ernest, Chris Romaniuk, Paula Ghaneh, Helen Wong, Marie McKay, Mona Chopra, Sarah Coupland, and Bertil Damato. "High-risk uveal melanoma: A prospective study evaluating the role of magnetic resonance imaging of the liver." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 8564. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.8564.
Full textRobinson, June K., Namita Jain, Ashfaq A. Marghoob, William McGaghie, Michael MacLean, Pedram Gerami, Brittney Hultgren, Rob Turrisi, Kimberly Mallett, and Gary J. Martin. "A Randomized Trial on the Efficacy of Mastery Learning for Primary Care Provider Melanoma Opportunistic Screening Skills and Practice." Journal of General Internal Medicine 33, no. 6 (February 5, 2018): 855–62. http://dx.doi.org/10.1007/s11606-018-4311-3.
Full textZhu, Lucía, Natalia Yebra, Diana Retana, Carmen Blanco-Aparicio, Sonia Martínez, Riccardo Soffietti, Luca Bertero, et al. "42. IDENTIFICATION OF BRAIN METASTASIS VULNERABILITIES USING METPLATFORM." Neuro-Oncology Advances 2, Supplement_2 (August 2020): ii8. http://dx.doi.org/10.1093/noajnl/vdaa073.030.
Full textLupo-Stanghellini, Maria Teresa, Giacomo Oliveira, Raffaella Greco, Luca Vago, Attilio Bondanza, Fabio Ciceri, Claudio Bordignon, and Chiara Bonini. "TK-Cells Safety and Efficacy in Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Clinical and Molecular Assessment in 128 Treated Patients." Blood 120, no. 21 (November 16, 2012): 3061. http://dx.doi.org/10.1182/blood.v120.21.3061.3061.
Full textOhmoto, Akihiro, Shinichi Yachida, and Chigusa Morizane. "Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer." International Journal of Molecular Sciences 20, no. 3 (January 29, 2019): 561. http://dx.doi.org/10.3390/ijms20030561.
Full textPrimiero, Clare A., Anna Finnane, Tatiane Yanes, Betsy Peach, H. Peter Soyer, and Aideen M. McInerney-Leo. "Protocol to evaluate a pilot program to upskill clinicians in providing genetic testing for familial melanoma." PLOS ONE 17, no. 12 (December 7, 2022): e0275926. http://dx.doi.org/10.1371/journal.pone.0275926.
Full textAnderson, Steven, Kenneth J. Bloom, Dino U. Vallera, Josef Rueschoff, Cliff Meldrum, Robert Schilling, Barbara Kovach, et al. "Multisite Analytic Performance Studies of a Real-Time Polymerase Chain Reaction Assay for the Detection of BRAF V600E Mutations in Formalin-Fixed, Paraffin-Embedded Tissue Specimens of Malignant Melanoma." Archives of Pathology & Laboratory Medicine 136, no. 11 (November 1, 2012): 1385–91. http://dx.doi.org/10.5858/arpa.2011-0505-oa.
Full textLocke, Darren, Steven Bernstein, Frank Lynch, Koushan Siami-Namini, Jackie M. Walling, Thomas Yonker, and Geoffrey Yarranton. "An IHC Screen For EphA3 Positive FFPE Tumors." Blood 122, no. 21 (November 15, 2013): 4965. http://dx.doi.org/10.1182/blood.v122.21.4965.4965.
Full textMaller, Bradley, Vani Nath Simmons, Margaret M. Byrne, and Tawee Tanvetyanon. "Outcomes of lung cancer screening among cancer survivors: An NCCN institution experience." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 1595. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1595.
Full textSnoswell, Centaine L., Jennifer A. Whitty, Liam J. Caffery, Lois J. Loescher, Nicole Gillespie, and Monika Janda. "Direct-to-consumer mobile teledermoscopy for skin cancer screening: Preliminary results demonstrating willingness-to-pay in Australia." Journal of Telemedicine and Telecare 24, no. 10 (October 22, 2018): 683–89. http://dx.doi.org/10.1177/1357633x18799582.
Full textHay, Jennifer L., Kimberly A. Kaphingst, David Buller, Elizabeth Schofield, Kirsten Meyer White, Andrew Sussman, Dolores Guest, et al. "Behavioral and Psychological Outcomes Associated with Skin Cancer Genetic Testing in Albuquerque Primary Care." Cancers 13, no. 16 (August 12, 2021): 4053. http://dx.doi.org/10.3390/cancers13164053.
Full textJohnson, Laura A., Richard A. Morgan, Mark E. Dudley, Lydie Cassard, James C. Yang, Marybeth S. Hughes, Udai S. Kammula, et al. "Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen." Blood 114, no. 3 (July 16, 2009): 535–46. http://dx.doi.org/10.1182/blood-2009-03-211714.
Full textButow, Phyllis N., Jane Turner, Jemma Gilchrist, Louise Sharpe, Allan Ben Smith, Joanna E. Fardell, Stephanie Tesson, et al. "Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence." Journal of Clinical Oncology 35, no. 36 (December 20, 2017): 4066–77. http://dx.doi.org/10.1200/jco.2017.73.1257.
Full textAthavale, Ambarish M. "Capsule Commentary on Robinson et al.: A Randomized Trial on the Efficacy of Mastery Learning on Primary Care Providers’ Melanoma Opportunistic Screening Skills and Practice." Journal of General Internal Medicine 33, no. 6 (February 15, 2018): 946. http://dx.doi.org/10.1007/s11606-018-4360-7.
Full textAmin, Asim, Mohammed M. Milhem, Georgina V. Long, Christopher J. Hoimes, Theresa Michelle Medina, Robert Martin Conry, Christopher D. Lao, et al. "Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced/metastatic melanoma resistant to anti-PD-1/PD-L1 therapy." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 9555. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.9555.
Full text